Todd Hieronymus is an experienced DMPK/In Vitro Scientist with a robust background in metabolic studies and assay development. They obtained a Bachelor of Science in Marine Biology from Texas A&M University and a Master's in Pharmacology from The University of Texas Medical Branch. Previously, Todd has held significant roles at Eli Lilly and Company, Quintiles, and Q² Solutions, focusing on CYP inhibition and in vitro metabolism. Currently, they serve as a Senior Principal Scientist DMPK at Eli Lilly, where they contribute to drug disposition parameters and assay automation efforts.
This person is not in the org chart
This person is not in any teams
This person is not in any offices